Multiregion human bladder cancer sequencing reveals tumour evolution, bladder cancer phenotypes and implications for targeted therapy
dc.contributor.author | Heide, T | en_US |
dc.contributor.author | Maurer, A | en_US |
dc.contributor.author | Eipel, M | en_US |
dc.contributor.author | Knoll, K | en_US |
dc.contributor.author | Geelvink, M | en_US |
dc.contributor.author | Veeck, J | en_US |
dc.contributor.author | Knuechel, R | en_US |
dc.contributor.author | van Essen, J | en_US |
dc.contributor.author | Stoehr, R | en_US |
dc.contributor.author | Hartmann, A | en_US |
dc.contributor.author | Altmueller, J | en_US |
dc.contributor.author | Graham, TA | en_US |
dc.contributor.author | Gaisa, NT | en_US |
dc.date.accessioned | 2019-10-22T09:26:32Z | |
dc.date.available | 2019-01-30 | en_US |
dc.date.issued | 2019-06 | en_US |
dc.identifier.issn | 0022-3417 | en_US |
dc.identifier.uri | https://qmro.qmul.ac.uk/xmlui/handle/123456789/60550 | |
dc.format.extent | 230 - 242 | en_US |
dc.language.iso | en | en_US |
dc.relation.ispartof | JOURNAL OF PATHOLOGY | en_US |
dc.rights | "This is the peer reviewed version of the following article: Heide, T. , Maurer, A. , Eipel, M. , Knoll, K. , Geelvink, M. , Veeck, J. , Knuechel, R. , van Essen, J. , Stoehr, R. , Hartmann, A. , Altmueller, J. , Graham, T. A. and Gaisa, N. T. (2019), Multiregion human bladder cancer sequencing reveals tumour evolution, bladder cancer phenotypes and implications for targeted therapy. J. Pathol., 248: 230-242. doi:10.1002/path.5250 which has been published in final form at https://doi.org/10.1002/path.5250. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versions." | |
dc.subject | bladder cancer | en_US |
dc.subject | phylogenetic analysis | en_US |
dc.subject | tumour heterogeneity | en_US |
dc.subject | tumour evolution | en_US |
dc.subject | tumour phenotype | en_US |
dc.subject | kataegis | en_US |
dc.title | Multiregion human bladder cancer sequencing reveals tumour evolution, bladder cancer phenotypes and implications for targeted therapy | en_US |
dc.type | Article | |
dc.identifier.doi | 10.1002/path.5250 | en_US |
pubs.author-url | http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000467873200010&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6a | en_US |
pubs.issue | 2 | en_US |
pubs.notes | Not known | en_US |
pubs.publication-status | Published | en_US |
pubs.volume | 248 | en_US |
rioxxterms.funder | Default funder | en_US |
rioxxterms.identifier.project | Default project | en_US |